Mergers and Acquisitions

The Federal Trade Commission is suing to block Kroger's proposed $24.6 billion deal to buy a major rival, saying it would lead to higher prices for millions of Americans.

FOX Business' Stuart Varney discusses the case of Tyler Loudon who pleaded guilty to securities fraud related to insider trading after eavesdropping on his wife's work calls.

Capital One's proposed purchase of Discover Financial is expected to face pushback from regulators, who are already being pressured by lawmakers to block the deal.

Capital One's $35.3 billion acquisition of Discover Financial would likely renew competition for Visa and Mastercard, which have long dominated the payment processing industry.

Walmart announced Tuesday it is buying smart-TV maker Vizio in a $2.3 billion acquisition aimed at boosting the retailer's growing advertising business.

Capital One is planning to buy Discover Financial Services that would bring the two large credit card issuers and lenders together, the company announced Monday.

Some pilots at Spirit Airlines are looking for new job opportunities after the Department of Justice blocked the budget carrier's proposed merger with JetBlue Airways last month.

The combined company would be the third-largest oil and gas producer in the region behind Exxon and Chevron, with both firms having announced recent deals.

U.S. Steel has allegedly "sold off to the highest bidder to line their own pockets," according to local union presidents who now worry about their job security and livelihoods.

Allen Media Group, run by media mogul Byron Allen, offered to buy Paramount Global in a deal worth more than $14 billion after a prior offer extended last year was rebuffed.

Macy's rejected a $5.8 billion bid from Arkhouse Management Co. LP and partner Brigade Capital Management LP to acquire all outstanding shares of Macy's.

Spirit Airlines is looking at ways to deal with its financial challenges, including $1.1B in debt, after a federal judge blocked the merger deal between it and JetBlue Airways

A federal district court on Tuesday blocked JetBlue Airways' proposed $3.8 billion acquisition of budget carrier Spirit Airlines after the judge found the merger would hurt competition.

The U.S. drugmaker is turning to deals at a time when two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, face generic competition.

Karuna’s crown jewel, an experimental drug called KarXT, is the product of such new insights. The drug could surpass $6 billion in yearly sales if it is approved for the various uses.